Lei Zhao
Company: Bristol Myers Squibb
Job title: Senior Director - Scientific
Seminars:
Reimagining Biomarkers to Illuminate the Right Patient Population & Advance Precision Medicine Impact 4:00 pm
Navigating biomarkers in cardiovascular drug development that span all modalities – genetics, peripheral proteins, lipids, inflammatory markers as well as imaging and device-derived markers De-risking cardiovascular outcome trials with early proof of concept biomarkers remains a major challenge Exploratory omic analyses in cardiovascular outcomes offer hypothesis generation for precision medicineRead more
day: Conference Day 2
Chair’s Closing Remarks 4:30 pm
day: Conference Day 2
Reimagining Biomarkers to Illuminate the Right Patient Population & Advance Precision Medicine Impact 9:00 am
Despite the ignited excitement for a next generation therapeutic with potential to reduce mortality, progress in clinical studies has been hindered by challenges in identifying suitable biomarkers. Join this interactive deep dive to harness biomarkers to better stratify patient populations and understand how best to target them to unlock the therapeutic potential of cardiovascular…Read more
day: Pre-Conference Workshop Day
High Collagen Type VI Formation Is a Strong and Independent Predictor of Poor Prognosis in HFpEF 2:00 pm
HFpEF is a highly heterogenous disease & patient stratification is essential to inform clinical trial Meta-analysis data demonstrated strong, independent prognostic value of PRO-C6 as a novel biomarker in HFpEF (NEJM Evidence 2022) FDA issued Letter of Support (LoS) to encourage further PRO-C6 work in HFpEFRead more
day: Conference Day 2
Chair’s Opening Remarks 8:55 am
day: Conference Day 2